Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Vancomycin (250mg) Injection
Therapeutic Category
Antibacterials
Dosage Form
Injection
Packaging Type
Vial
Packaging
250mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vancoterm 250 Injection containing Vancomycin is used for the management of serious bacterial infections. It helps control infection-causing bacteria and supports effective antibacterial treatment in critical care settings.
Vancomycin works as a glycopeptide antibiotic that inhibits bacterial cell wall synthesis, thereby helping eliminate susceptible gram-positive bacteria effectively.
The injection is widely prescribed in hospital and intensive care settings for severe infections including bloodstream, respiratory, skin, bone, and resistant bacterial infections, leading to consistent institutional demand.
With increasing prevalence of resistant bacterial infections and rising demand for advanced injectable antibiotics, this product offers strong business potential for retailers and distributors. Its potent antibacterial action, broad clinical relevance, and steady market demand make it a reliable product for growth in the critical care anti-infective segment.
Some patients may experience injection site reactions, nausea, fever, rash, or low blood pressure during infusion. Rarely, kidney toxicity, hearing impairment, or severe allergic reactions may occur and require immediate medical attention.
Vancoterm 250 Injection is indicated for severe skin and soft tissue infections, septicemia, endocarditis, pneumonia, bone and joint infections, and infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and other susceptible gram-positive bacteria. It helps eliminate resistant bacteria and improve clinical recovery.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Kidney function and drug level monitoring may be required during prolonged therapy. Infuse slowly as directed to reduce infusion-related reactions.
Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vancomycin 250mg Injection has high-value, specialized demand in the hospital, ICU, and critical-care anti-infective segment, making it a premium product for distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotic portfolios.
Distributors and agencies can benefit from consistent hospital demand for severe bacterial infection management under strict medical supervision. Vancomycin 250mg is a glycopeptide antibiotic Commonly used for serious gram-positive infections, including MRSA (Methicillin-resistant Staphylococcus aureus), sepsis, endocarditis, pneumonia, and complicated skin infections Widely used in ICUs, surgical wards, oncology units, and emergency care settings Reserved for resistant infections where other antibiotics are ineffective Administered only under hospital monitoring due to its potent action and safety requirements This strengthens a high-value critical-care and resistant infection management portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vancomycin Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high institutional demand, ICU-based usage, low competition, and specialist-driven prescriptions, along with reliable supply chain support and strong margin potential in the critical-care antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for advanced hospital business growth.